{"id":456246,"date":"2021-03-11T14:40:39","date_gmt":"2021-03-11T19:40:39","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456246"},"modified":"2021-03-11T14:40:39","modified_gmt":"2021-03-11T19:40:39","slug":"surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/","title":{"rendered":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D."},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., March  11, 2021  (GLOBE NEWSWIRE) &#8212; Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced the addition of Mary Haak-Frendscho, Ph.D., to the Board of Directors. Dr. Haak-Frendscho currently serves as the president and chief executive officer of Spotlight Therapeutics.<\/p>\n<p>\u201cDr. Haak-Frendscho\u2019s achievements as a scientist and executive in the biotechnology industry will be invaluable in guiding our growth to a clinical stage company and in expanding the therapeutic breadth of our platforms,\u201d said Craig Parker, president and chief executive officer at Surrozen. \u201cOur novel approach to selectively harnessing the potential of the Wnt pathway has far-reaching therapeutic potential and I look forward to Dr. Haak-Frendscho\u2019s contributions to our mission.\u201d<\/p>\n<p>Dr. Haak-Frendscho brings over two decades of expertise in the discovery, translation and early development of novel therapeutics. Prior to Spotlight, she was a venture partner with Versant Ventures and the chief executive officer of Blueline Bioscience, Versant\u2019s vehicle for new company creation in Canada. Earlier, Dr. Haak-Frendscho established and served as the chair of Compugen USA, was the chief executive officer of Igenica Biotherapeutics, and was the founding president and chief scientific officer of Takeda San Francisco. She began her industry career at Genentech, where she played a key role in the development of omalizumab (Xolair\u00ae).\u00a0<\/p>\n<p>&#8220;Surrozen\u2019s progress validating precision modulation of Wnt signaling pathways has the potential to transform the treatment of severe disease through selective tissue regeneration. I\u2019m excited to be joining the Surrozen Board as it begins to advance novel drug candidates into clinical development and explore the full potential of Wnt biology,\u201d said Dr. Haak-Frendscho.<\/p>\n<p>Dr. Haak-Frendscho has authored or co-authored 70 scientific publications and is an inventor on over 40 patents. An immunologist by training, she received her B.S. from the University of Michigan, M.L.A. from Washington University, M.S. from SUNY-Stony Brook, C.S.E.P. from Columbia University Graduate School of Business, and Ph.D. from the University of Wisconsin.<\/p>\n<p>\n        <strong>About Surrozen<\/strong><br \/>\n        <br \/>Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body\u2019s existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and\u00a0certain neurological disorders. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-nwjfHKja2o-3bbTdS0qg-KQGxfrMv0IWSPx6SHYY0yi47489_opkHAQlxbfDsbxFfEmEGRHdoS7LKfKQfGoFQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">surrozen.com<\/a>.<\/p>\n<p>\n        <strong>Investors\/ Media:<\/strong><br \/>\n        <br \/>Reza Afkhami<br \/>VP, Corporate Development and Strategy<br \/>Surrozen, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NPRv6uZkPzrKgPcabGnStv4SVQHCnwk9x031sGyW2qXFoCOuRbKPGxngCrs67Eu7ZJmxyNiCzu9V8da4WXXN1Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">reza@surrozen.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e43fdb27-78e5-4b19-a8f8-b62970554e21\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) &#8212; Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced the addition of Mary Haak-Frendscho, Ph.D., to the Board of Directors. Dr. Haak-Frendscho currently serves as the president and chief executive officer of Spotlight Therapeutics. \u201cDr. Haak-Frendscho\u2019s achievements as a scientist and executive in the biotechnology industry will be invaluable in guiding our growth to a clinical stage company and in expanding the therapeutic breadth of our platforms,\u201d said Craig Parker, president and chief executive officer at Surrozen. \u201cOur novel approach to selectively harnessing the potential of the Wnt pathway has far-reaching therapeutic potential and I look forward to Dr. Haak-Frendscho\u2019s contributions &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456246","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) &#8212; Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced the addition of Mary Haak-Frendscho, Ph.D., to the Board of Directors. Dr. Haak-Frendscho currently serves as the president and chief executive officer of Spotlight Therapeutics. \u201cDr. Haak-Frendscho\u2019s achievements as a scientist and executive in the biotechnology industry will be invaluable in guiding our growth to a clinical stage company and in expanding the therapeutic breadth of our platforms,\u201d said Craig Parker, president and chief executive officer at Surrozen. \u201cOur novel approach to selectively harnessing the potential of the Wnt pathway has far-reaching therapeutic potential and I look forward to Dr. Haak-Frendscho\u2019s contributions &hellip; Continue reading &quot;Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T19:40:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.\",\"datePublished\":\"2021-03-11T19:40:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/\"},\"wordCount\":424,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/\",\"name\":\"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\",\"datePublished\":\"2021-03-11T19:40:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/","og_locale":"en_US","og_type":"article","og_title":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) &#8212; Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced the addition of Mary Haak-Frendscho, Ph.D., to the Board of Directors. Dr. Haak-Frendscho currently serves as the president and chief executive officer of Spotlight Therapeutics. \u201cDr. Haak-Frendscho\u2019s achievements as a scientist and executive in the biotechnology industry will be invaluable in guiding our growth to a clinical stage company and in expanding the therapeutic breadth of our platforms,\u201d said Craig Parker, president and chief executive officer at Surrozen. \u201cOur novel approach to selectively harnessing the potential of the Wnt pathway has far-reaching therapeutic potential and I look forward to Dr. Haak-Frendscho\u2019s contributions &hellip; Continue reading \"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T19:40:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D.","datePublished":"2021-03-11T19:40:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/"},"wordCount":424,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/","name":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=","datePublished":"2021-03-11T19:40:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4ODczOSM0MDYwNDgxIzIxOTU5MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-expands-board-of-directors-with-appointment-of-mary-haak-frendscho-ph-d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Surrozen Expands Board of Directors with Appointment of Mary Haak-Frendscho, Ph.D."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456246"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456246\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}